Inhaltsbereich
| 18 Einträge |
Seite 1 / 1
 Druckansicht
|
| Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. |
| Sahin E, Haubenwallner S, Kuttke M, Kollmann I, Halfmann A, Dohnal AM, Dohnal AB, Chen L, Cheng P, Hoesel B, Einwallner E, Brunner J, Kral JB, Schrottmaier WC, Thell K, Saferding V, Blüml S, Schabbauer G |
| Journal of immunology (Baltimore, Md. : 1950). 2014 Jul 11. pii: jimmunol.1302167. doi: 10.4049/jimmunol.1302167. pmc: PMC4120896 |
| PMID: 25015834 |
| Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. |
| Traxlmayr MW, Wesch D, Dohnal AM, Funovics P, Fischer MB, Kabelitz D, Felzmann T |
| Journal of immunotherapy (Hagerstown, Md. : 1997). 2009 Dec 24. doi: 10.1097/CJI.0b013e3181b51447 |
| PMID: 19952957 |
| Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition. |
| Kuttke M, Sahin E, Pisoni J, Percig S, Vogel A, Kraemmer D, Hanzl L, Brunner JS, Paar H, Soukup K, Halfmann A, Dohnal AM, Steiner CW, Blüml S, Basilio J, Hochreiter B, Salzmann M, Hoesel B, Lametschwandtner G, Eferl R, Schmid JA, Schabbauer G |
| Oncoimmunology. 2016 Mar 28. doi: 10.1080/2162402X.2016.1164918. pii: 1164918 |
| PMID: 27622019 |
| Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study. |
| Eder J, Rogojanu R, Jerney W, Erhart F, Dohnal A, Kitzwögerer M, Steiner G, Moser J, Trautinger F |
| PloS one. 2016 Nov 28. doi: 10.1371/journal.pone.0163661. pii: PONE-D-16-27343 |
| PMID: 27893746 |
| Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response. |
| Soukup K, Halfmann A, Dillinger B, Poyer F, Martin K, Blauensteiner B, Kauer M, Kuttke M, Schabbauer G, Dohnal AM |
| Scientific reports. 2017 Sep 18. doi: 10.1038/s41598-017-12208-7. pii: 10.1038/s41598-017-12208-7 |
| PMID: 28924177 |
| CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity. |
| Dillinger B, Ahmadi-Erber S, Soukup K, Halfmann A, Schrom S, Vanhove B, Steinberger P, Geyeregger R, Ladisch S, Dohnal AM |
| Frontiers in immunology. 2017 Sep 20. doi: 10.3389/fimmu.2017.01152. pmc: PMC5611377 |
| PMID: 28979262 |
| IFN-γ and tumor gangliosides: Implications for the tumor microenvironment. |
| Dillinger B, Ahmadi-Erber S, Lau M, Hoelzl MA, Erhart F, Juergens B, Fuchs D, Heitger A, Ladisch S, Dohnal AM |
| Cellular immunology. 2018 Feb 2. pii: S0008-8749(18)30016-9. doi: 10.1016/j.cellimm.2018.01.014 |
| PMID: 29402391 |
| Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature. |
| Erhart F, Blauensteiner B, Zirkovits G, Printz D, Soukup K, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Lötsch D, Spiegl-Kreinecker S, Berger W, Visus C, Dohnal A |
| Journal of cellular and molecular medicine. 2018 Nov 22. doi: 10.1111/jcmm.13927 |
| PMID: 30467961 |
| Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. |
| Erhart F, Buchroithner J, Reitermaier R, Fischhuber K, Klingenbrunner S, Sloma I, Hibsh D, Kozol R, Efroni S, Ricken G, Wöhrer A, Haberler C, Hainfellner J, Krumpl G, Felzmann T, Dohnal AM, Marosi C, Visus C |
| Acta neuropathologica communications. 2018 Dec 5. doi: 10.1186/s40478-018-0621-2. pii: 10.1186/s40478-018-0621-2 |
| PMID: 30518425 |
| Loss of JAK1 Drives Innate Immune Deficiency. |
| Witalisz-Siepracka A, Klein K, Prinz D, Leidenfrost N, Schabbauer G, Dohnal A, Sexl V |
| Frontiers in immunology. 2019 Jan 8. doi: 10.3389/fimmu.2018.03108. pmc: PMC6331462 |
| PMID: 30671064 |
| Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production. |
| Erhart F, Weiss T, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Blauensteiner B, Lötsch D, Spiegl-Kreinecker S, Berger W, Sialana FJ, Lubec G, Felzmann T, Dohnal A, Visus C |
| Cytotherapy. 2019 Apr 8. pii: S1465-3249(19)30038-6. doi: 10.1016/j.jcyt.2019.03.002 |
| PMID: 30975602 |
| Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors. |
| Erhart F, Hackl M, Hahne H, Buchroithner J, Meng C, Klingenbrunner S, Reitermaier R, Fischhuber K, Skalicky S, Berger W, Spiegl-Kreinecker S, Lötsch D, Ricken G, Kuster B, Wöhrer A, Widhalm G, Hainfellner J, Felzmann T, Dohnal AM, Marosi C, Visus C |
| NPJ vaccines. 2020 Jan 16. doi: 10.1038/s41541-019-0149-x. pii: 149. pmc: PMC6965118 |
| PMID: 31969991 |
| STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity. |
| Meissl K, Simonović N, Amenitsch L, Witalisz-Siepracka A, Klein K, Lassnig C, Puga A, Vogl C, Poelzl A, Bosmann M, Dohnal A, Sexl V, Müller M, Strobl B |
| Frontiers in immunology. 2020 Sep 11. doi: 10.3389/fimmu.2020.02189. pmc: PMC7519029 |
| PMID: 33042133 |
| Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors. |
| Erhart F, Hackl M, Hahne H, Buchroithner J, Meng C, Klingenbrunner S, Reitermaier R, Fischhuber K, Skalicky S, Berger W, Spiegl-Kreinecker S, Lötsch D, Ricken G, Kuster B, Wöhrer A, Widhalm G, Hainfellner J, Felzmann T, Dohnal AM, Marosi C, Visus C |
| NPJ vaccines. 2020 Jan 16. doi: 10.1038/s41541-019-0149-x. pii: 10.1038/s41541-019-0149-x |
| PMID: 33446641 |
| CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression. |
| Michael Dohnal A, Luger R, Paul P, Fuchs D, Felzmann T |
| Journal of cellular and molecular medicine. doi: 10.1111/j.1582-4934.2008.00584.x. pmc: PMC6529981 |
| PMID: 20187300 |
| JAK1 signaling in dendritic cells promotes peripheral tolerance in autoimmunity through PD-L1-mediated regulatory T cell induction. |
| Vogel A, Martin K, Soukup K, Halfmann A, Kerndl M, Brunner JS, Hofmann M, Oberbichler L, Korosec A, Kuttke M, Datler H, Kieler M, Musiejovsky L, Dohnal A, Sharif O, Schabbauer G |
| Cell reports. pii: S2211-1247(22)00144-9. doi: 10.1016/j.celrep.2022.110420 |
| PMID: 35196494 |
| Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants. |
| Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Devignot S, Klingström J, Thålin C, Kellner MJ, Christ W, Havervall S, Mereiter S, Knapp S, Sanchez Jimenez A, Bugajska-Schretter A, Dohnal A, Ruf C, Gugenberger R, Hagelkruys A, Montserrat N, Kozieradzki I, Hasan Ali O, Stadlmann J, Holbrook MR, Schmaljohn C, Oostenbrink C, Shoemaker RH, Mirazimi A, Wirnsberger G, Penninger JM |
| EMBO molecular medicine. 2022 Jul 4. doi: 10.15252/emmm.202115230 |
| PMID: 35781796 |
| Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants. |
| Wirnsberger G, Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Jimenez AS, Bugajska-Schretter A, Dohnal A, Ruf C, Gugenberger R, Hagelkruys A, Montserrat N, Holbrook MR, Oostenbrink C, Shoemaker RH, Mirazimi A, Penninger JM |
| bioRxiv : the preprint server for biology. 2021 Sep 10. doi: 10.1101/2021.09.10.459744. pmc: PMC8452097 |
| PMID: 34545368 |
| 18 Einträge |
Seite 1 / 1
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
